查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614301

女性不孕症診斷和治療市場：按產品、治療、診斷、不孕原因和最終用戶 - 2025-2030 年全球預測

Female Infertility Diagnosis & Treatment Market by Product (Accessories, Equipment, Media), Treatment (Assisted Reproductive Technology, Medication, Surgery), Diagnosis, Cause of Infertility, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年女性不孕症診斷與治療市值為18.1億美元，預計2024年將達19.6億美元，複合年成長率為8.11%，到2030年將達到31.4億美元。

女性不孕症診斷和治療市場包括用於診斷和治療女性不孕症的各種方法和技術，解決生理和生活方式相關的原因。由於延遲懷孕、荷爾蒙失調和平均生育年齡上升等因素導致不孕率上升，因此需要此類解決方案，這凸顯了對高效診斷和治療系統的需求。應用範圍主要包括輔助生殖技術（ART），例如體外受精（IVF）、卵巢刺激通訊協定、手術介入和藥物治療。最終用途包括生育診所、醫院和手術中心，它們提供有針對性的解決方案，並在研究投資和政府支持下形成重要的細分市場。

主要市場統計
基準年[2023] 18.1億美元
預計年份 [2024] 19.6億美元
預測年份 [2030] 31.4億美元
複合年成長率（%） 8.11%

根據市場洞察，關鍵的成長要素包括生殖技術的進步、對不孕症治療的認知和接受度的提高以及醫療保健支出的增加。此外，政府為 ART 治療提供保險的措施和公共衛生宣傳活動代表了市場擴張的潛在機會。印度和中國都是新興市場，醫療基礎設施不斷發展，潛力巨大，尤其是透過與當地醫療保健提供者的合作夥伴關係。然而，挑戰包括治療成本上升、欠開發中地區缺乏認知以及有關 ART 的倫理問題。此外，農村地區對先進醫療技術的接受度有限限制了市場滲透。

創新和研究的最佳領域包括開發具有成本效益且易於使用的不孕症治療解決方案、增強 ART 技術以及整合用於病患監測和個人化治療計劃的數位技術。此外，研究影響不孕症的遺傳和生活方式因素可能會開闢新的治療途徑。市場的本質是動態的，持續的技術和監管變化需要相關人員採取適應性策略。對於尋求抓住新機會的公司來說，培養與生物技術公司的合作夥伴關係、注重宣傳活動以及參與以客戶為中心的研究對於克服挑戰和推動成長至關重要。

市場動態：揭示快速發展的女性不孕症診斷和治療市場的關鍵市場洞察

供需的動態交互作用正在改變女性不孕症診斷和治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 女性生殖和不孕問題的盛行率上升
    • 政府促進獲得生殖保健解決方案的舉措
    • 擴大生育診所的範圍和對生殖問題的認知
  • 市場限制因素
    • 缺乏熟練人員以及識別和治療不孕問題的複雜性
  • 市場機會
    • 持續創新，提高女性不孕症診療方案的有效性和準確性
    • 對管理生殖問題的新創新和解決方案提供有利的監管支持
  • 市場挑戰
    • 關於女性不孕症診斷和治療方案的準確性和副作用的治療問題

波特五力：引領女性不孕症診斷與治療市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對女性不孕症診斷和治療市場的影響

外部宏觀環境因素對女性不孕症診斷和治療市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解女性不孕症診斷和治療市場的競爭狀況

對女性不孕症診斷和治療市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣女性不孕診斷與治療市場供應商績效評估

FPNV定位矩陣是評估女性不孕症診斷和治療市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，描繪女性不孕症診斷和治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對女性不孕症診斷和治療市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 女性生殖和不孕問題增加
      • 政府促進獲得生殖保健解決方案的舉措
      • 生育診所正在世界各地擴張，提高了人們對生殖問題的認知。
    • 抑制因素
      • 缺乏熟練人員以及識別和治療不孕問題的複雜性
    • 機會
      • 持續創新，提高女性不孕症診療方案的有效性和準確性
      • 對管理生殖問題的新創新和解決方案提供有利的監管支持
    • 任務
      • 對女性不孕症診斷和治療方案準確性和副作用的擔憂
  • 市場區隔分析
    • 產品：擴大支持胚胎體外生長和存活的培養基解決方案的引入
    • 最終使用者：生育診所專業生殖照護的首選
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章女性不孕診斷與治療市場：依產品

  • 配件
  • 裝置
  • 媒體

第7章 依治療方式分類的女性不孕不孕診療市場

  • 輔助生殖技術
  • 藥物治療
  • 外科手術

第8章 女性不孕不孕診療市場（依診斷）

  • 子宮鏡檢查
  • 影像檢查
  • 排卵測試

第9章依不孕原因分類的女性不孕不孕診療市場

  • 子宮內膜異位症
  • 排卵障礙
  • 輸卵管堵塞

第10章女性不孕症診斷與治療市場：依最終使用者分類

  • 不孕不育治療診所
  • 醫院
  • 調查機構

第11章 北美和南美女性不孕症診斷和治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區女性不孕診斷與治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東、非洲女性不孕不孕診療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 羽扇豆向美國市場推出新的非專利不孕症治療藥物
    • Arva Health 為印度女性提供創新的家庭不孕症測試
    • Trajan Scientific 和德國Start-UpsFertilly 在歐洲推出以微採樣為基礎的不孕症檢測套組
  • 戰略分析和建議

公司名單

  • Bayer AG
  • Cook Group Incorporated
  • CooperSurgical Inc.
  • Ferring BV
  • FUJIFILM Irvine Scientific, Inc. by FUJIFILM Holdings Corporation
  • Genea Pty Limited
  • GlaxoSmithKline PLC
  • Halotech DNA SL
  • Intas Pharmaceuticals Ltd.
  • Lupin Limited
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi SA
  • SCSA Diagnostics, Inc.
  • Theramex by Kanga Health Ltd
  • Vitrolife Sweden AB
Product Code: MRR-FE70EC183B6E

The Female Infertility Diagnosis & Treatment Market was valued at USD 1.81 billion in 2023, expected to reach USD 1.96 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 3.14 billion by 2030.

The female infertility diagnosis and treatment market encompasses various methods and technologies used to diagnose and treat infertility in women, addressing both physiological and lifestyle-related causes. The necessity for these solutions is driven by increasing infertility rates due to factors such as delayed pregnancies, hormonal imbalances, and rising average ages at childbirth, emphasizing the need for efficient diagnosis and treatment systems. Application scope primarily involves assisted reproductive technologies (ART) like in-vitro fertilization (IVF), ovarian stimulation protocols, surgical interventions, and medication. End-use includes fertility clinics, hospitals, and surgical centers, which provide targeted solutions, thereby forming a crucial market segment driven by research investments and governmental support.

KEY MARKET STATISTICS
Base Year [2023] USD 1.81 billion
Estimated Year [2024] USD 1.96 billion
Forecast Year [2030] USD 3.14 billion
CAGR (%) 8.11%

Market insights reveal that key growth factors include advancements in reproductive technologies, increased awareness and acceptance of infertility treatments, and rising healthcare expenditures. Further, government initiatives providing insurance coverage for ART procedures and public health campaigns are potential opportunities to expand market reach. India and China, with their growing healthcare infrastructures, represent emerging markets with significant potential, particularly through collaborations and partnerships with local healthcare providers. However, limitations such as high costs of treatment, lack of awareness in less developed regions, and ethical concerns regarding ART pose challenges. Moreover, the limited reach of advanced medical technologies in rural areas restricts market penetration.

The best areas for innovation and research include developing cost-effective and accessible fertility treatment solutions, enhancements in ART techniques, and digital technology integration for patient monitoring and personalized treatment plans. Additionally, research into genetic and lifestyle factors affecting fertility could unveil new treatment avenues. The market nature is dynamic, with continuous technological and regulatory changes necessitating adaptive strategies for stakeholders. For businesses aiming to seize emerging opportunities, fostering collaborations with biotechnology firms, focusing on awareness campaigns, and engaging in customer-centric research will be paramount to navigate challenges and stimulate growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Female Infertility Diagnosis & Treatment Market

The Female Infertility Diagnosis & Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of reproductive and fertility issues among women
    • Government initiatives to promote access to reproductive healthcare solutions
    • Expansion of fertility clinics across the world and expanding awareness about reproductive issues
  • Market Restraints
    • Lack of skilled personnel and complexity of identifying and treating fertility issues
  • Market Opportunities
    • Ongoing innovations to improve the effectiveness and accuracy of female infertility diagnosis and treatment solutions
    • Favorable regulatory support for new innovations and solutions for managing reproductive issues
  • Market Challenges
    • Concerns related to the accuracy and side effects of female infertility diagnosis and treatment solutions

Porter's Five Forces: A Strategic Tool for Navigating the Female Infertility Diagnosis & Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Female Infertility Diagnosis & Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Female Infertility Diagnosis & Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Female Infertility Diagnosis & Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Female Infertility Diagnosis & Treatment Market

A detailed market share analysis in the Female Infertility Diagnosis & Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Female Infertility Diagnosis & Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Female Infertility Diagnosis & Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Female Infertility Diagnosis & Treatment Market

A strategic analysis of the Female Infertility Diagnosis & Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Female Infertility Diagnosis & Treatment Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Cook Group Incorporated, CooperSurgical Inc., Ferring B.V., FUJIFILM Irvine Scientific, Inc. by FUJIFILM Holdings Corporation, Genea Pty Limited, GlaxoSmithKline PLC, Halotech DNA S.L., Intas Pharmaceuticals Ltd., Lupin Limited, Merck & Co., Inc., Novartis AG, Sanofi SA, SCSA Diagnostics, Inc., Theramex by Kanga Health Ltd, and Vitrolife Sweden AB.

Market Segmentation & Coverage

This research report categorizes the Female Infertility Diagnosis & Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Equipment, and Media.
  • Based on Treatment, market is studied across Assisted Reproductive Technology, Medication, and Surgery.
  • Based on Diagnosis, market is studied across Hysteroscopy, Imaging Tests, and Ovulation Testing.
  • Based on Cause of Infertility, market is studied across Endometriosis, Ovulatory Disorders, and Tubal Occlusion.
  • Based on End User, market is studied across Fertility Clinics, Hospitals, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of reproductive and fertility issues among women
      • 5.1.1.2. Government initiatives to promote access to reproductive healthcare solutions
      • 5.1.1.3. Expansion of fertility clinics across the world and expanding awareness about reproductive issues
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled personnel and complexity of identifying and treating fertility issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations to improve the effectiveness and accuracy of female infertility diagnosis and treatment solutions
      • 5.1.3.2. Favorable regulatory support for new innovations and solutions for managing reproductive issues
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to the accuracy and side effects of female infertility diagnosis and treatment solutions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing incorporation of media solutions as it support the growth and viability of embryos outside the body
    • 5.2.2. End User: Fertility clinics' first-line choice for specialized reproductive care
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Female Infertility Diagnosis & Treatment Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Equipment
  • 6.4. Media

7. Female Infertility Diagnosis & Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Assisted Reproductive Technology
  • 7.3. Medication
  • 7.4. Surgery

8. Female Infertility Diagnosis & Treatment Market, by Diagnosis

  • 8.1. Introduction
  • 8.2. Hysteroscopy
  • 8.3. Imaging Tests
  • 8.4. Ovulation Testing

9. Female Infertility Diagnosis & Treatment Market, by Cause of Infertility

  • 9.1. Introduction
  • 9.2. Endometriosis
  • 9.3. Ovulatory Disorders
  • 9.4. Tubal Occlusion

10. Female Infertility Diagnosis & Treatment Market, by End User

  • 10.1. Introduction
  • 10.2. Fertility Clinics
  • 10.3. Hospitals
  • 10.4. Research Institutes

11. Americas Female Infertility Diagnosis & Treatment Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Female Infertility Diagnosis & Treatment Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Female Infertility Diagnosis & Treatment Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Lupin Introduces New Generic Infertility Treatment in the U.S. Market
    • 14.3.2. Arva Health's Innovative At-Home Fertility Test for Indian Women
    • 14.3.3. Trajan Scientific and German Startup Fertilly Introduce Microsampling-based Fertility Test Kits in Europe
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bayer AG
  • 2. Cook Group Incorporated
  • 3. CooperSurgical Inc.
  • 4. Ferring B.V.
  • 5. FUJIFILM Irvine Scientific, Inc. by FUJIFILM Holdings Corporation
  • 6. Genea Pty Limited
  • 7. GlaxoSmithKline PLC
  • 8. Halotech DNA S.L.
  • 9. Intas Pharmaceuticals Ltd.
  • 10. Lupin Limited
  • 11. Merck & Co., Inc.
  • 12. Novartis AG
  • 13. Sanofi SA
  • 14. SCSA Diagnostics, Inc.
  • 15. Theramex by Kanga Health Ltd
  • 16. Vitrolife Sweden AB

LIST OF FIGURES

  • FIGURE 1. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OVULATION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OVULATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TUBAL OCCLUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023